Affymetrix Inc. AFFX recently announced that it has entered into a strategic partnership with Cytox, a developer of assays for risk assessment and prediction of dementia. Under the terms of the deal, ...

SANTA CLARA, Calif., May 10, 2010 (BUSINESS WIRE) -- Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has delivered the first custom array designed for a 100,000-sample genotyping project to be ...

In the wake of Thermo Fisher Scientific, Inc.'s TMO impending acquisition of Affymetrix, Inc. AFFX, the latter has finally chosen to stick to Thermo Fisher's $1.3 billion takeover bid. With this ...

Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...

Affymetrix (AFFX) stock is surging on heavy trading volume on Monday after the company announced it was being acquired by Thermo Fisher Scientific for about $1.3 billion.

(NASDAQ: AFFX) today announced the expansion of its license agreement with Siemens Healthcare Diagnostics for the company’s branched DNA (bDNA) technology whereby Affymetrix is the exclusive licensee ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq: AFFX) today announced that Dr. Frank Witney has been appointed president and chief executive officer, effective July 1, 2011. Dr. Witney ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ:AFFX) today announced that it has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based ...

Thermo Fisher Scientific Inc.TMO3.46%increase; up pointing triangle will buy Affymetrix Inc. in a roughly $1.3 billion cash deal that would boost its biogenetic analysis portfolio, the company said ...

Affymetrix, Inc. has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay ...